Harvard: Potential Mechanism Driving Personalization of Cancer Immunotherapy Harvard: Potential Mechanism Driving Personalization of Cancer Immunotherapy Another breakthrough in...
CAR-T
New breakthrough in CAR-T cell therapy: Lupus erythematosus patients achieved treatment-free remission for up to 17 months New breakthrough...
Five lupus patients enter long-term remission after experimental immunotherapy Five lupus patients enter long-term remission after experimental immunotherapy. Scientists...
Capstan Therapeutics: Injecting mRNA to generate CAR-T in vivo Capstan Therapeutics: Injecting mRNA to generate CAR-T in vivo. The...
The introduction of Novartis CD19 CAR-T with T-chargeTM process The introduction of Novartis CD19 CAR-T with T-chargeTM process. ...
How does CAR-T cell therapy treat Acute Myeloid Leukemia (AML)? How does CAR-T cell therapy treat Acute Myeloid Leukemia...
